Characteristics and clinical courses in a monocentric NSCLC cohort with MET exon 14 skipping mutations
G. Rafflenbeul (Berlin, Germany), C. Lips (Berlin, Germany), T. Blum (Berlin, Germany), M. Hollmann (Berlin, Germany), J. Kollmeier (Berlin, Germany), D. Misch (Berlin, Germany), S. Stephan-Falkenau (Berlin, Germany), A. Streubel (Berlin, Germany), S. Thiel (Berlin, Germany), T. Mairinger (Berlin, Germany), T. Bauer (Berlin, Germany), C. Lips (Kleinmachnow, Germany)
Source: International Congress 2022 – Identification of therapeutic strategies in lung cancer
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Rafflenbeul (Berlin, Germany), C. Lips (Berlin, Germany), T. Blum (Berlin, Germany), M. Hollmann (Berlin, Germany), J. Kollmeier (Berlin, Germany), D. Misch (Berlin, Germany), S. Stephan-Falkenau (Berlin, Germany), A. Streubel (Berlin, Germany), S. Thiel (Berlin, Germany), T. Mairinger (Berlin, Germany), T. Bauer (Berlin, Germany), C. Lips (Kleinmachnow, Germany). Characteristics and clinical courses in a monocentric NSCLC cohort with MET exon 14 skipping mutations. 1925
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|